home / stock / atxi / atxi news

ATXI News and Press, Avenue Therapeutics Inc. From 01/05/24

Stock Information
Company Name: Avenue Therapeutics Inc.
Stock Symbol: ATXI
Market: NASDAQ
Website: avenuetx.com
Menu
ATXI ATXI Quote ATXI Short ATXI News ATXI Articles ATXI Message Board
Get ATXI Alerts

News, Short Squeeze, Breakout and More Instantly...
ATXI - Avenue Therapeutics signs warrant exercise transactions for $5.0M in proceeds

2024-01-05 09:33:29 ET More on Avenue Therapeutics Avenue Therapeutics GAAP EPS of $0.06 beats by $0.32 Avenue Therapeutics stock plummets on pricing of 16.6M units at $0.3006 in public offering Seeking Alpha’s Quant Rating on Avenue Therapeutics Histo...
ATXI - Avenue Therapeutics Enters into Warrant Exercise Transactions for $5.0 Million in Proceeds

MIAMI, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced the...

ATXI - 24/7 Market News Wrap 4 Jan 2024

2024-01-04 21:57:41 ET DENVER, Colo., Jan. 4, 2024 ( www.247marketnews.com )- 24/7 Market News covered the following companies today; Omega Therapeutics, Inc. (NASDAQ: OMGA), Avenue Therapeutics, Inc. (NASDAQ: ATXI), QuantumScape (NYSE: QS), Jeffs Brands Ltd (NASDAQ: JFBR), Dyne Therape...

ATXI - OGEN, RLMD and ATXI among mid-day movers

2024-01-04 12:34:16 ET More on Mid-day movers & Stocks. Relmada Therapeutics, Inc. (RLMD) Q3 2023 Earnings Call Transcript Relmada And REL-1017: Intriguing Underlying Efficacy In MDD Ahead Of Eventful 2024 Avenue Therapeutics GAAP EPS of $0.06 beats by $0.32 ...
ATXI - 24/7 Market News Lunch Break 4 Jan 2024

2024-01-04 12:31:41 ET DENVER, Colo., Jan. 4, 2024 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Omega Therapeutics Inc (NASDAQ: OMGA), Avenue Therapeutics Inc (NASDAQ: ATXI), Nikola Corp (NASDAQ: NKL...

ATXI - 24/7 Market News Snapshot 4 Jan 2024

2024-01-04 10:00:42 ET DENVER, Colo., Jan. 4, 2024 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Omega Therapeutics Inc (NASDAQ: OMGA), Avenue Therapeutics Inc (NASDAQ: ATXI), Rapid Micro Biosystems Inc (NAS...

ATXI - Watch this One After Reaching Final Agreement with the U.S. FDA for the Phase 3 Safety Study for IV Tramadol

2024-01-04 08:58:40 ET DENVER, Colo., Jan. 4, 2024 ( www.247marketnews.com )- Avenue Therapeutics, Inc. (NASDAQ: ATXI) reported, this morning, that it reached final agreement with the U.S. Food and Drug Administration (“FDA”) on the Phase 3 safety study protocol and statis...
ATXI - Avenue Therapeutics Reaches Final Agreement with the U.S. FDA for the Phase 3 Safety Study for IV Tramadol

MIAMI, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced tha...

ATXI - Avenue Therapeutics Announces Completion of Enrollment in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)

- Topline data remains on track for second quarter of 2024 - MIAMI, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of th...

ATXI - Avenue Therapeutics to Present at American Epilepsy Society 2023 Annual Meeting

MIAMI, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced tha...
Previous 10 Next 10